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Coeliac disease (CD) is a chronic, immune-mediated small intestinal enteropathy, accompanied with gluten-triggered oxidative
damage of duodenal mucosa. Previously, our research group reported an increased mucosal level of the antioxidant protein
Parkinson’s disease 7 (PARK7) in children with CD. In the present study, we investigated the role of increased PARK7 level on
the epithelial cell and mucosal integrity of the small intestine. The presence of PARK7 was investigated using
immunofluorescent staining on duodenal mucosa of children with CD and on FHs74Int duodenal epithelial cells. To investigate
the role of oxidative stress, FHs74Int cells were treated with H2O2 in the absence or presence of Comp23, a PARK7-binding
compound. Intracellular accumulation of reactive oxygen species (ROS) was determined by DCFDA-based assay. Cell viability
was measured by MTT, LDH, and Annexin V apoptosis assays. Disruption of cytoskeleton and cell adhesion was investigated by
immunofluorescence staining and by real-time RT PCR. Effect of PARK7 on mucosal permeability was investigated ex vivo
using intestinal sacs derived from control and Comp-23-pretreated mice. Comp23 treatment reduced the H2O2-induced
intracellular accumulation of ROS, thus preserving the integrity of the cytoskeleton and also the viability of the FHs74Int cells.
Accordingly, Comp23 treatment increased the expression of antioxidants (NRF2, TRX1, GCLC, HMOX1, NQO1), cell-cycle
regulators (TP53, CDKN1A, PCNA, BCL2, BAX), and cell adhesion molecules (ZO1, CDH1, VCL, ITGB5) of H2O2-treated cells.
Pretreatment with Comp23 considerably decreased the small intestinal permeability. In this study, we demonstrate that PARK7-
binding Comp23 reduces the oxidative damage of duodenal epithelial cells, via increased expression of NRF2- and P53-
regulated genes. Our results suggest that PARK7 plays a significant role in the maintenance of mucosal integrity in CD.
1. Introduction
Coeliac disease (CD) is a chronic, immune-mediated small
intestinal enteropathy triggered by the ingestion of gluten
in the genetically predisposed individuals [1]. Degraded
gluten peptides and the resulting chronic inflammation
induce excessive accumulation of reactive oxygen species
(ROS) [2], leading to the injury of the epithelial layer and
the subsequent deterioration of mucosal integrity [3, 4].
Parkinson’s disease 7 (PARK7) is a multifunctional
molecule, which is primarily investigated in connection with
neurodegenerative diseases [5, 6]; however, its possible role
has been suggested in other diseases, as well [7]. Previously,
our research group reported elevated expression of PARK7
in the duodenal mucosa of therapy-naive children with CD
[8], and genome-wide association studies identified PARK7
polymorphisms as a predisposing factor in CD [9] and
ulcerative colitis [10].
The cytoprotective effect of PARK7 can be exerted
through various mechanisms. Among others, PARK7 is sug-
gested to exert antioxidative defence directly via its enzy-
matic and chaperon activity; however, PARK7 influences
the degree of oxidative damage more likely through its tran-
scriptional regulatory effect. PARK7 as an oxidative sensor
stabilizes transcription factors, including NRF2 and P53 in
an oxidation-dependent manner. Indeed, in response to
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oxidative stress due to its conformation changes, PARK7
releases these transcription factors, allowing them to translo-
cate into the nucleus and to induce the expression of stress-
response elements [11, 12]. These mechanisms altogether
moderate the oxidative damage of intracellular macromole-
cules, promote repair processes, and enhance the viability
of the affected cells.
In the present study, we aimed to investigate the possible
role of PARK7 in the pathomechanism of CD, with particular
attention on oxidative damage of intestinal epithelial cells.
2. Methods
2.1. Duodenal Biopsies. Mucosal biopsies of pediatric
therapy-naive CD patients and controls were collected at
the 1st Department of Paediatrics, Semmelweis University,
Hungary. Written informed consent was obtained from the
parents of each participant prior to the procedure, and the
study was approved by the Semmelweis University Regional
and Institutional Committee of Science and Research Ethics
(TUKEB 58/2013). CD was diagnosed based on the criteria
of the European Society for Pediatric Gastroenterology,
Hepatology, and Nutrition [13]. Controls were referred with
chronic abdominal pain, growth retardation, and diarrhoea,
and an upper gastrointestinal endoscopy was part of their
diagnostic procedure. Biopsy samples were immediately
snap-frozen and stored at −80°C until further analysis.
2.2. Ex Vivo Mucosal Permeability Measurement. All experi-
ments were approved by the institutional committee on ani-
mal welfare (PEI/OO1/83-4/2013). Intestinal permeability
was measured based on Mateer et al. and Lange et al. [14,
15]. Briefly, 2 cm long intestinal sacs were prepared from
the small intestine of untreated (controls) and Comp23
([N-[4-(8-methyl(4-hydroimidazo[1,2-a]pyridin-2-yl)) phe-
nyl] (3,4,5-trimethoxyphenyl) carboxamide]; AKSci, Union
City, CA, USA) pretreated (10mg/kg, intraperitoneally, 1
hour before experiment) C57Bl/6J mice (n = 7‐9/group).
The intestinal sacs were equally filled with 0.1% Evans blue
diluted either in Dulbecco’s modified Eagle medium
(DMEM; Thermo Fisher Scientific, Waltham, MA, USA) or
in DMEM supplemented with H2O2 (1000μM) and placed
into 5ml phosphate-buffered saline (PBS) at 37°C. The per-
meation of Evans blue was measured in every 20 minutes at
590nm in a Hidex Chameleon Microplate Reader (Triathler,
Plate Chameleon, 300SL Lablogic Systems, Inc., Brandon, FL,
USA) using the MikroWin 2000 program.
2.3. FHs74Int Small Intestinal Epithelial Cell Culture.Human
small intestinal epithelial cell line (FHs74Int (CCL-241),
American Type Culture Collection, Manassas, VA, USA)
was cultured in Hybri Care Medium (American Type Culture
Collection) supplemented with 30 ng/ml EGF, 10% heat-
inactivated fetal bovine serum (FBS) (Invitrogen, Carlsbad,
CA, USA), and 1% penicillin and streptomycin mixture
(Sigma-Aldrich Co., St. Louis, MO, USA) under standard cell
culture conditions (37°C, humidified, 5% CO2/95% air
environment).
For ROS assays, cells were seeded into 96-well plates at a
density of 104 cells/well (n = 5 well/treatment group) and
treated with Comp23 (0.001μM) overnight, thereafter with
H2O2 (50, 100, 250, 500, 1000μM) (Sigma-Aldrich) for 30
minutes. For MTT and LDH assays, cells were seeded into
96-well plates at a density of 104 cells/well (n = 5 well/treat-
ment group) and treated with Comp23 (0.0001, 0.001, 0.01,
0.1, 1μM) overnight, thereafter with H2O2 (1000μM) for
24 h. For Annexin V apoptosis assay, cells were seeded into
6-well plates at a density of 3 × 105 cells/well and treated with
Comp23 (0.001μM) overnight, thereafter with H2O2
(1000μM) for 24 hours, then measured in triplicates (n = 9
/treatment group). For real-time RT-PCRs, cells were seeded
into 96 well plates at a density of 104 cells/well (n = 5 well/-
treatment group) and treated with Comp23 (0.001μM) over-
night, thereafter with H2O2 (1000μM) for 24 hours. For
immunocytochemistry, cells were seeded into 4 well cham-
bers at a density of 8 × 104 cells/well and treated with
Comp23 (0.001μM) overnight, thereafter with H2O2
(1000μM) for 4 hours. Vehicle-treated cells served as
controls in all experiments.
2.4. MTT Cell Proliferation Assay. MTT cell proliferation
assay was performed using the Cell Proliferation Kit I
(MTT) (Roche Diagnostics) according to the manufacturer’s
recommendations. Absorbance was recorded at 570nm and
690 nm as background using a Hidex Chameleon Microplate
Reader using the MikroWin 2000 program.
2.5. LDH Cytotoxicity Assay. Reagents for in vitro LDH cyto-
toxicity assay [16] were purchased from Sigma-Aldrich.
Absorbance was recorded at 570 nm and 690nm as back-
ground in a Hidex Chameleon Microplate Reader using the
MikroWin 2000 program.
2.6. Apoptosis Detection Assay. Apoptosis assay was per-
formed using the FITC Annexin V Apoptosis Detection Kit
I (BD Pharmingen) according to the manufacturer’s recom-
mendations. Cells that are negative for Annexin V and PI
were referred to as viable, cells that are positive for Annexin
V and negative for PI were referred as early apoptotic, and
cells that are positive for both Annexin V and PI were
referred as late apoptotic cells. Flow cytometry analysis was
performed using a FACS Aria cytometer (BD).
2.7. ROS Assay. Intracellular ROS accumulation was mea-
sured using 2′,7′-dichlorofluorescein diacetate (DCFDA,
Sigma-Aldrich) fluorescent dye [17]. Cells were washed twice
with PBS; thereafter, 50μl of DCFDA solution (5μM in PBS)
was added for each well and incubated for 30 minutes in cell
culture incubator. The fluorescence signal was measured for
30 minutes in every 5 minutes after induction of oxidative
stress in the Hidex Chameleon Microplate Reader (λexc:
485 nm, λem: 535 nm) using MikroWin 2000 program.
2.8. RNA Isolation, Reverse Transcription, and Real-Time RT-
PCR. Total RNA was isolated from FHs74Int cells by Gen-
eaid Total RNA Mini Kit (Geneaid Biotech Ltd., New Taipei
City, Taiwan). Equal RNA was reverse-transcribed using
Maxima First Strand cDNA Synthesis Kit for RT-qPCR (Life
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Technologies) to generate the first-stranded cDNA. The
mRNA expressions were determined by real-time RT-PCR
using the LightCycler 480 SYBR Green I Master enzyme
mix on a Light Cycler 480 system (Roche Diagnostics, Mann-
heim, Germany). The nucleotide sequences of the primer
pairs are shown in Table 1. The results were analyzed by
the LightCycler 480 software version 1.5.0.39 (Roche
Diagnostics). The relative mRNA expression was determined
in comparison with RN18S as an internal control using the
ΔΔCt method [18]. Data were normalized and presented as
the ratio of their control values.
2.9. Immunofluorescence Staining. The localization of
PARK7, ZO-1, and the cytoskeletal actin architecture was
investigated by immunofluorescence staining on frozen
biopsy samples and FHs74Int cells. After repeated washing
Table 1: Nucleotide sequences of primer pairs applied for the real-time polymerase chain reaction (RT-PCR) detection. Abbreviations: ref.
seq.: reference sequence; F: forward; R: reverse.
Gene NCBI ref. seq. Primer pairs
BAX NM_001291428.2
F: 5′- GGA TGA TTG CCG CCG TGG ACA CAG -3′
R: 5′-CAA CAG CCG CTC CCG GAG GAA GTC-3′
BCL2 NM_000633.2
F: 5′-CGG GGT GAA CTG GGG GAG GAT TGT-3′
R: 5′-AGG TGT GCA GGT GCC GGT TCA GGT-3′
CDH1 NM_004360.4
F: 5′-AAGGAGGCGGAGAAGAGGACCAG-3′
R: 5′-GAT TGG CAG GGC GGG GAA G-3′
CDKN1A NM_001220777.1
F: 5′-TTG TAC CCT TGT GCC TCG CTC AGG-3′
R: 5′-ATC AGC CGG CGT TTG GAG TGG TAG-3′
GCLC NM_001498.4
F: 5′-AAA AGT CCG GTT GGT CCT GTC TGG-3′
R: 5′-GGC TGT CCT GGT GTC CCT TCA ATC-3′
HMOX1 NM_002133.2
F: 5′-CCA GCG GGC CAG CAA CAA AG-3′
R: 5′-TGT CGC CAC CAG AAA GCT GAG TGT-3′
ITGB5 NM_002213.5
F: 5′- TCC GCC ATC TGC TGC CTC TCA C-3′
R: 5′-CAT CCT TTC GCC AGC CAA TCT TCT C-3′
NQO1 NM_000903.3
F: 5′-CTG CTG CAG CGG CTT TGA AGA-3′
R: 5′-GCC AGA ACA GAC TCG GCA GGA TAC-3′
NRF2 NM_006164.4
F: 5′-CAG CAG GAC ATG GAT TTG ATT G-3′
R: 5′-ACT GGT TTC TGA CTG GAT GTG CT-3′
PCNA NM_002592.2
F: 5′-GCG GTC TGA GGG CTT CGA CAC CTA-3′
R: 5′-CCG CGT TAT CTT CGG CCC TTA GTG-3′
RN18S HQ387008.1
F: 5′-GGC GGC GAC GAC CCA TTC-3′
R: 5′-TGG ATG TGG TAG CCG TTT CTC AGG-3′
TP53 NM_001126118.1
F: 5′-TGG TCT GGC CCC TCC TCA GCA TCT-3′
R: 5′-TCA GGC GGC TCA TAG GGC ACC AC-3′
TRX1 NM_003329.3
F: 5′-ATG CAT GCC AAC ATT CCA GTT TT-3′
R: 5′-ATG GTG GCT TCA AGC TTT TCC TTA-3′
VCL NM_014000.2
F: 5′-CCA CGG CGC CTC CTG ATG C-3′
R: 5′-GGC CTG AAT GCC TTC CAC TGT TGA-3′
ZO1 NM_021258.3
F: 5′-ACC ACA AGC GCA GCC ACA ACC AAT-3′
R: 5′-GGG GTG GGC TCC TCC AGT CTG ACA T-3′
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with PBS, slides were permeabilized with Cytofix/Cytoperm
(BD Pharmingen, San Diego, CA, USA) for 15 minutes at
RT, washed with Perm/Wash Buffer solution (BD Pharmin-
gen), and incubated with a primary antibody specific for
PARK7 (ab18257; rabbit, 1 : 1000, Abcam, Cambridge, US),
ZO-1 (ab96587; rabbit, 1 : 1000, Abcam), or Alexa Fluor®
546 phalloidin (7.5 units/mL, A22283; Thermo Fisher Scien-
tific) for 1 hour at RT. In case of PARK7 and ZO-1 staining,
slides were incubated with antirabbit Alexa Fluor 568®-
conjugated secondary antibody (1 : 1000, A11036; Thermo
Fisher Scientific) or antirabbit Alexa Fluor 488®-conjugated
secondary antibody (1 : 1000, A21206; Thermo Fisher Scien-
tific) for 30 minutes at RT. Thereafter, the slides were washed
with a Perm/Wash Buffer solution and coverslipped with
ProLong™ Gold Antifade Mountant with DAPI (Thermo
Fisher Scientific). Sections were analyzed with an Olympus
IX81 fluorescent microscope system.
2.10. Graphical Analysis of Damaged Cell Ratio. The ratio of
phalloidin-stained FHs74Int cells with different cytoskeletal
status was analyzed. The images were taken with 10x objec-
tive, and each cell from the field of view (n = 400‐500/treat-
ment group) was categorised manually into three groups.
Thereafter, cells with a healthy cytoskeleton, cells with a
damaged cytoskeleton, and burst cells were counted using
the ImageJ 1.48 software (The National Institutes of Health,
Bethesda).
2.11. Statistical Analysis. The statistical evaluation of data
was performed by the GraphPad Prism 6.01 software
(GraphPad Software Inc., La Jolla, CA, USA). After testing
normality with the Kolmogorov-Smirnov test, the raw data
of real-time RT-PCR measurements were analyzed with the
Mann–Whitney U test to determine the differences between
the corresponding groups. Multiple comparisons of raw data
derived from MTT, LDH, Annexin V apoptosis, ROS assays,
and ex vivo mucosal permeability measurements were per-
formed using multiple t-test and ordinary two-way ANOVA
with Dunnett correction. The ratio of cells with healthy or
damaged cytoskeleton after various treatments was
compared using the chi-square test. p ≤ 0:05 was considered
as statistically significant.
3. Results
3.1. The Presence of PARK7 in Duodenal Epithelial Cells. An
increased PARK7 immunopositivity was observed in the epi-
thelial cells of the duodenal crypt and in the lamina propria
of duodenal biopsies derived from children with CD com-
pared to controls (Figure 1(a)). A definite PARK7 immuno-
positivity was also present in the cytoplasm and nucleus of
FHs74Int cells (Figure 1(b)).
3.2. Comp23 Prevented Intracellular ROS Accumulation. The
effect of Comp23 on the H2O2-induced ROS accumulation in
the FHs74Int duodenal epithelial cells was investigated by
DCFDA-based ROS assay (Figures 2(a) and 2(b)). The treat-
ment with H2O2 resulted in an increasing accumulation of
ROS in a dose-dependent manner, which was reduced by
0.001μM Comp23 at each H2O2 concentration.
The oxidative stress induced by H2O2 resulted in
decreased NRF2, NQO1, and GCLC and elevated HMOX1
mRNA levels, while cotreatment with Comp23 increased
the expression of NRF2, HMOX1, NQO1, TRX1, and GCLC
(Figure 2(c)).
Control











Figure 1: The presence of PARK7 in duodenal epithelial cells. Localization of PARK (red) was investigated by immunofluorescence staining
in duodenal mucosa of children with celiac disease (CD) and controls (a) and in FHs74Int cells (b). Cell nuclei were counterstained with DAPI
(blue). Scale bar: 200, 100, or 50μm.
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3.3. Comp23 Protected Cells against Oxidative Stress-Induced
Cytotoxicity. The effect of Comp23 treatment on the H2O2-
induced cytotoxicity of FHs74Int duodenal epithelial cells
was investigated by MTT, LDH, and Annexin V apoptosis
assays. The treatment with H2O2 resulted in decreased viabil-
ity, which was significantly restored by Comp23 at a wide
concentration range (Figure 3(a)). Accordingly, the enzyme
activity of LDH, released from the injured cells, was signifi-
cantly lower in the supernatant of Comp23-treated cells
(Figure 3(b)). Similarly, the Comp23 treatment significantly
reduced the percentage of apoptotic cells in the H2O2-treated
group (Figures 3(c) and 3(d)).
The oxidative stress induced by H2O2 resulted in
decreased TP53, BCL2, and BAX and elevated PCNA mRNA
levels, while cotreatment with Comp23 increased the expres-
sion of TP53, PCNA, CDKN1A, BCL2, and BAX (Figure 3(e)).
3.4. Comp23 Improved the Cytoskeletal Status under
Oxidative Conditions. The architecture of the actin cytoskel-
eton of mucosal epithelial cells was visualized by phalloidin
staining in duodenal biopsy samples of children with CD
and controls and also in FHs74Int epithelial cells
(Figure 4(a)). The fluorescence signal was intense and con-
tinuous at the apical, basal, and lateral surface of the epithe-
lial cells both in the villi and in the crypts of the control
children. However, the healthy architecture of the actin cyto-
skeleton was disturbed in the mucosal epithelial cells of chil-
dren with CD, and instead, granular staining appeared in the
cytoplasm. The H2O2 treatment disrupted the actin filaments
of the FHs74Int cells shrinking them into intracellular dots.
In some cells, oxidative stress led to cell death as indicated
by the increased number of burst cells (white arrows).
Comp23 treatment of the cells largely reduced the signs of
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Figure 2: Effect of Comp23 on ROS accumulation inFHs71Int cells. FHs74Int duodenal epithelial cells were treated with different
concentrations of H2O2 in the absence or presence of Comp23 (0.001 μM). Scatter plot (a) serves as a representative figure of the time-
related fluorescence intensity after treatment with 1000 μM H2O2 with or without Comp23. Violin plot (b) indicates the slope distribution
of time-related DCFDA fluorescence intensity change in the given group at different concentrations of H2O2. Relative mRNA expressions
(c) at 1000μM H2O2 concentration were determined by comparison with 18S ribosomal RNA as an internal control. Results are presented
as mean + SD (n = 5). $p < 0:05 vs. Ø compound at the concerning H2O2 concentration (multiple t-test); ∗p < 0:05 vs. control+Ø
compound (Mann-Whitney U test); #p < 0:05 vs. H2O2+Ø compound (Mann–Whitney U test).
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oxidative damages, the structure of the actin cytoskeleton
remained mainly intact, and only a few granular dots were
present (Figure 4(b)). The ratio of damaged and dead cells
was also reduced by Comp23 after treatment with H2O2
(Figure 4(c)).
3.5. Comp23 Prevented Cell Adhesion Damage Induced by
Oxidative Stress. Localisation of actin cytoskeleton and cell
adhesion molecules was visualized by phalloidin and immu-
nofluorescence staining of the FHs74Int cells, respectively
(Figure 5(a)). In control cells with healthy cytoskeleton,
ZO-1 co-localized with the actin filaments. In H2O2 treated
cells actin fibers aggregated into dots and ZO-1 was released
from cytoskeleton and dispersed into cytoplasm. These
effects of oxidative stress were diminished by the Comp23-
treatment of the cells. Similarly, Comp23 treatment increased
the expression of ZO1, CDH1, VCL and ITGB5 cell adhesion
molecules (CAMs) of H2O2 treated FHs74Int cells
(Figure 5(b)).
3.6. Comp23 Prevented the Mucosal Permeability. Intestinal
sacs prepared from the small intestine of the control and
Comp23-pretreated mice were used to investigate the role
of PARK7 in the oxidative stress-induced mucosal perme-
ability. Oxidative stress induced by H2O2 increased the per-
meability of the sacs derived from the control or Comp23-
pretreated mice. However, Comp23 pretreatment decreased
the permeability of sacs whether treated with H2O2 or not
compared to the corresponding sacs derived from the
untreated control mice (Figure 6).
4. Discussion
Oxidative stress and consequent accumulation of damaged
intracellular macromolecules [19, 20] are important compo-
nents of mucosal deterioration and increased intestinal per-
meability of patients with CD [21]. Recently, Moretti et al.
reported that the production of ROS strictly correlates with
the severity of intestinal damage; therefore, they recom-
mended the routine determination of serum antioxidant
capacity to monitor the efficiency of the gluten-free diet of
patients with CD [22].
Previously, our research group demonstrated the
increased presence of PARK7 in the small intestinal mucosa
of children with CD [8]. PARK7 is an ubiquitously expressed
antioxidant protein, in which significance is clearly demon-
strated in the pathomechanism of different neurodegenera-
tive diseases [12]. However, our knowledge is limited about
the possible role of PARK7 in the preservation of the epithe-
lial layer integrity in the inflamed intestine.
In the present study, in accordance with our previous
study [8], we found that PARK7 is abundantly present in
the duodenal epithelial cells of therapy-naive children with
CD, and also in FHs74Int duodenal epithelial cells (Figure 1).
Therefore, in the following experiments, FHs74Int cells
exposed to oxidative stress were used to investigate the role
of PARK7 in the maintenance of mucosal integrity. In these
experiments, Comp23, a PARK7-binding compound devel-
oped by Kitamura et al. [23, 24], was used to enhance the
antioxidant activity of PARK7. They suggest that Comp23
can prevent the excessive oxidation of PARK7 by binding
to its C106 cysteine residue, thereby preserving the antioxi-
dant function of PARK7.
In the first set of experiments, we found that Comp23
decreased the intracellular accumulation of ROS in H2O2-
treated FH74Int cells (Figure 2). Our result is in line with pre-
vious studies demonstrating that treatment with recombi-
nant PARK7 decreased the oxidative stress-induced ROS
accumulation in neuronal cells [25, 26]. Similarly, previous
studies also demonstrated that the lack of PARK7 is associ-
ated with enhanced ROS accumulation in various cell types
proposing the determinative role of PARK7 in the antioxi-
dant defence [27–29].
Investigating the molecular mechanism by which PARK7
may modulate the oxidative stress, we found that Comp23




































































































































































Figure 3: Effect of Comp23 on the H2O2-induced cell death of FHs71Int cells. FHs74Int duodenal epithelial cells were treated with different
concentrations of Comp23 in the absence or presence of H2O2 (1000 μM); then, oxidative stress-induced cytotoxicity was determined by
MTT (a), LDH (b), and Annexin V apoptosis ((c, d); 0.001μM Comp23) assays. Relative mRNA expressions (e) at 0.001μM Comp23
concentration were determined by comparison with 18S ribosomal RNA as an internal control. Results are presented as mean + SD ((a, b,
e): n = 5; (c): n = 9). ∗p < 0:05 vs. control+Ø compound ((a, b, c): multiple t-test; (e): Mann-Whitney U test); #p < 0:05 vs. H2O2+Ø
compound ((a, b, c): two-way ANOVA; (e): Mann-Whitney U test).
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Figure 4: Cytoskeletal disruption of intestinal mucosa in celiac disease (CD) and of duodenal epithelial cells. Actin filament structure was
investigated by phalloidin (orange) staining in duodenal mucosa of children with CD and controls (a) and in FHs74Int duodenal epithelial
cells (b) after treatment with H2O2 (1000 μM) in the absence or presence of Comp23 (0.001 μM). Cell nuclei were counterstained with
DAPI (blue). White arrows indicate burst cells. Scale bar: 500μm, 100 μm, and 50 μm. The percent of intact and damaged cells (c) was
determined by graphical analysis. Results are presented as the percentage of total cells in a field of view (n = 400‐500/treatment group). ∗p
< 0:05 vs. control+Ø compound; #p < 0:05 vs. H2O2+Ø compound (chi-square test).














































































































































Figure 5: Damage of cell adhesion in epithelial cells induced by oxidative stress. Colocalization of actin (red) and zonula occludens 1 (ZO-1,
green) was investigated by immunofluorescence staining (a) in FHs74Int duodenal epithelial cells after treatment with H2O2 (1000 μM) in the
absence or presence of Comp23 (0.001 μM). Cell nuclei were counterstained with DAPI (blue). Scale bar: 50 μm. Relative mRNA expressions
(b) in FHs74Int cells were determined by comparison with 18S ribosomal RNA as an internal control. Results are presented as mean + SD
(n = 5). ∗p < 0:05 vs. control+Ø compound (Mann-Whitney U test); #p < 0:05 vs. H2O2+Ø compound (Mann-Whitney U test).
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erythroid 2-related factor 2 (NRF2) transcription factor,
which is known as one of the major regulators of cellular
antioxidant defence. In accordance, we found that Comp23
treatment increased the expression of a multitude of NRF2-
dependent antioxidant response genes, including thioredoxin
(TRX1), γ-glutamyl cysteine synthetase (GCLC), heme oxy-
genase (HMOX1), and NAD(P)H:quinone oxidoreductase 1
(NQO1) of the H2O2-treated FHs74Int cells (Figure 2). Our
findings, in line with the literature, strongly suggest that
Comp23 significantly influences the activation of the
PARK7-NRF2 axis thereby influencing the consequence of
oxidative stress [30, 31]. Indeed, previously, it has been
shown that the activation of the NRF2 pathway attenuates
the stress-related apoptosis in numerous cell types [32–34].
In accordance with decreased intracellular ROS accumu-
lation and increased antioxidant preparedness of the epithe-
lial cells, we demonstrated that Comp23 treatment improved
the survival of H2O2-treated cells (Figure 3). Our finding is in
accordance with the results of Kitamura et al., describing for
the first time the PARK7-dependent protective effect of
Comp23 against H2O2-induced cell death in neuroblasts
[23, 24]. Investigating the possible molecular mechanism,
we found that Comp23 treatment increased the expression
of tumor antigen P53 (TP53) transcription factor and its tar-
get genes [35], including cyclin-dependent kinase inhibitor
1-p21 (CDKN1A), proliferating cell nuclear antigen (PCNA),
apoptosis regulator Bcl-2 (BCL2), and apoptosis regulator
BAX (BAX) (Figure 3). These results are in accordance with
the previous findings, demonstrating that PARK7 modulates
P53-P21 pathway in an oxidation status-dependent manner
[36]. P53 is a determinative regulator of the cell cycle, having
a dual function during stress response as it prevents intracel-
lular oxidation to ensure cell survival and repair at a low level
of damage, but it also can induce apoptosis in case of severe
cellular injury [37, 38]. Taken together, our results suggest
that the antiapoptotic effect of Comp23 is owing to the
combined activation of NRF2 and P53 pathways.
In the next set of experiments, we investigated the role of
PARK7 in the maintenance of mucosal integrity of CD
patients. Investigating the duodenal biopsies of CD patients,
we found that the actin cytoskeleton of epithelial cells is seri-
ously injured. Indeed, we found that the well-contoured
structure of the actin belts, a characteristic for the healthy
cells, collapsed resulting in granular dots in the epithelial cells
of inflamed mucosa (Figure 4).
Examining the effect of oxidative stress on FHs74Int cells,
we found that similarly to the duodenal epithelial cells of the
inflamed mucosa, the H2O2 treatment destroyed the filamen-
tous actin network of the cells, resulting in dot-like aggre-
gates (Figure 4). The oxidative damage also decreased the
expression of CAMs, including zonula occludens 1 (ZO1),
CDH1, VCL, and ITGB5, and led to the dissociation of ZO-
1 from the cytoskeleton of the cells (Figure 5). Our observa-
tion is in line with previous literary knowledge about the oxi-
dative stress-induced structural and functional modification
of intracellular macromolecules, including filamentous actin
resulting in its depolymerisation and thereby the disruption
of the physiological cytoskeleton [39]. Actin filaments are
associated with the intracellular localisation of CAMs,
including cadherins, tight-junction, and focal adhesion pro-
teins [40, 41], ensuring the stable cell surface and cell-cell
adhesion and thereby the maintenance of the mucosal barrier
function [42, 43]. Interestingly, we also observed that the
Comp23 treatment increased the expression of CAMs and,
more importantly, preserved the healthy architecture of the
actin cytoskeleton-CAM complexes in the epithelial cells
exposed to oxidative stress (Figures 4 and 5).
Therefore, to further investigate the significance of
PARK7 in the maintenance of the mucosal integrity, we
examined its effect on the permeability of H2O2-treated small
intestinal tissue preparations ex vivo. According to our previ-
ous in vitro experiments, we found that Comp23 greatly
decreased the permeability of the small intestinal sacs
(Figure 6), confirming that PARK7 has a determinative role
in the control of oxidative stress and in the maintenance of
mucosal integrity. The damage of the intestinal barrier leads
to increased penetration of luminal noxious molecules,
including gliadin or luminal bacteria into the lamina propria
of the intestine thereby exacerbating mucosal inflammation
of patients with CD [40]. Therefore, the preservation of the
intestinal barrier may offer a new therapeutic approach to
inhibit intestinal inflammation in CD patients.
5. Conclusion
In summary, we demonstrated the protective effect of the
PARK7-binding Comp23 in the duodenal epithelial cells
exposed to oxidative stress. We showed that PARK7 induced
the expression of stress-response elements, including antiox-
idant and cell-cycle regulator genes, and normalized the




































Figure 6: Mucosal permeability of small intestinal sacs of untreated
and Comp23-treated mice. Permeability of small intestinal sacs
derived from control and Comp23 pretreated mice, filled with
0.1% Evans blue diluted in DMEM were investigated in the
absence or presence of H2O2 (1000 μM). The permeation of Evans
blue was measured in every 20 minutes at 590 nm. The results are
presented as mean ± SEM (n = 7‐9). ∗p < 0:05 0μM H2O2 vs.
1000μM H2O2; #p < 0:05 0μM H2O2 vs. 0 μM H2O2+Comp23; $
p < 0:05 1000 μM H2O2 vs. 1000μM H2O2+Comp23 at the
concerning time (two-way ANOVA).
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expression of CAMs in the epithelial cells exposed to oxida-
tive stress (Figure 7). These processes contribute to the main-
tenance of mucosal integrity as demonstrated by our ex vivo
experiment and thereby may moderate the small intestinal
inflammation in CD.
Although there are limitations of our study, including the
lack of quantitative measurement at the protein level, we
hope that our study made a great progress in the understand-
ing of the biological effects of PARK7 in the pathomechanism
of CD. Moreover, our present work may contribute not only
to the better understanding of the pathomechanism of CD,
but also to the development of new therapeutic approaches.
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